Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2003
10/01/2003CN1446104A Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
10/01/2003CN1445243A Fab antibody of human resourced neutrality genetic engineering for anti human cytomegalo virus
10/01/2003CN1445242A Human resourced monoclone antibody of anti-blood-vessel endothelium growth factor as well as its preparing method and medicine composition
10/01/2003CN1445241A Monochain antibody with dual specificities possessing activity for restraining adherence and aggregation of blood platelets
10/01/2003CN1444992A Method and combination for treating tumors based on ERBB-3
10/01/2003CN1122533C Pigment labelled protein composite and its preparing method
10/01/2003CN1122532C Pigment marked protein composite and its preparing method
09/2003
09/30/2003US6627747 Essential bacterial genes and their use
09/30/2003US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it
09/30/2003US6627739 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease
09/30/2003US6627730 Of given amino acid sequence, and diagnostic test kit; multidrug resistance
09/30/2003US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with
09/30/2003US6627458 Nuclear envelope protein for use in the diagnosis of autoimmune disorders
09/30/2003US6627439 Cancer diagnosis, therapy; Dna vaccine
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627414 Genetic engineering; overlapping Dna sequences
09/30/2003US6627405 53BP2 complexes
09/30/2003US6627395 Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1)
09/30/2003US6627204 Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses
09/30/2003US6627196 Dosages for treatment with anti-ErbB2 antibodies
09/30/2003US6627195 Binding agents to CD23
09/30/2003US6627194 Activated immunoglobulin
09/30/2003CA2262465C Neuritin, a neurogene
09/30/2003CA2140921C Method and kit for pyridinium crosslink assay
09/30/2003CA2133759C Evaluation and treatment of patients with progressive immunosuppression
09/25/2003WO2003079025A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
09/25/2003WO2003078637A2 Optimizing glycan processing in plants
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078617A1 Production of usppase
09/25/2003WO2003078616A1 Production of ugppase
09/25/2003WO2003078600A2 Human monoclonal antibodies to influenza m2 protein and methods of making and using same
09/25/2003WO2003078469A1 Anti-human hepatoma monoclonal antibody hab18 light/heavy chain variable region gene, and use thereof
09/25/2003WO2003078468A2 Use of an active substance that binds to cd28 for producing a pharmaceutical composition
09/25/2003WO2003078465A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
09/25/2003WO2003078463A1 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy
09/25/2003WO2003078453A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003WO2003077947A1 Methods of modulating cd200 receptors
09/25/2003WO2003077946A1 Medicinal agent and method for curing pathologic syndrome associated to hemodyscrasia
09/25/2003WO2003077945A1 Intracellular antibodies
09/25/2003WO2003077943A2 Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound
09/25/2003WO2003077872A2 Cell surface tropomyosin as a target of angiogenesis inhibition
09/25/2003WO2003077863A2 Method for overexpression of zwitterionic polysaccharides
09/25/2003WO2003077858A2 Humanized antibodies that recognize beta amyloid peptide
09/25/2003WO2003077836A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/25/2003WO2003077658A1 Re-activated t-cells for adoptive immunotherapy
09/25/2003WO2003046001A3 Protein biopolymer markers predictive of insulin resistance
09/25/2003WO2003042402A3 Agents that modulate immune cell activation and methods of use thereof
09/25/2003WO2003042245B1 Growth hormone variations in humans and their uses
09/25/2003WO2003040185A3 Anti-n-glycolyl-neuraminic acid antibodies and their use for identifying glycoproteins
09/25/2003WO2003035682A3 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications
09/25/2003WO2003025181A3 Dna sequences that encode variable regions of antibodies that bind to the prion protein (prp), and prp-binding polypeptides
09/25/2003WO2003013577A3 Use of il-18 inhibitors in hypersensitivity disorders
09/25/2003WO2003011910A3 Anti-ssrp-1 monoclonal antibodies and hybridomas producing said antibodies
09/25/2003WO2003008454A3 Glycoprotein vi fusion proteins
09/25/2003WO2003004627A3 Novel human hepatoma lines, methods for obtaining same and uses thereof
09/25/2003WO2003000737A3 MOUSE μ LIGHT CHAIN LOCUS
09/25/2003WO2002102985A3 Pate, a gene expressed in prostate cancer, prostate and testis, and uses thereof
09/25/2003WO2002100998A3 Method for generating diversity
09/25/2003WO2002092635A3 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
09/25/2003WO2002085300A3 Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts
09/25/2003WO2002083850A8 Vascular endothelial growth factor 2
09/25/2003WO2002077263A3 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
09/25/2003WO2002064634A3 Human monoclonal antibodies to fc alpha receptor (cd89)
09/25/2003WO2002064612A9 Human g-protein chemokine receptor (ccr5) hdgnr10
09/25/2003WO2002063004A3 G-protein coupled receptors
09/25/2003WO2002046419A3 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
09/25/2003WO2002031146A3 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
09/25/2003WO2002028355A3 Methods and compositions for enhancing angiogenesis
09/25/2003WO2002026982A3 Secreted human proteins
09/25/2003WO2002024910A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
09/25/2003WO2002014489A9 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
09/25/2003WO2002014361A3 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER
09/25/2003WO2002008282A3 Bstp-ras/rerg protein and related reagents and methods of use thereof
09/25/2003US20030182682 Bacillus crystal proteins having improved insecticidal activity; immunodetection kits; transgenic plants
09/25/2003US20030182675 Functional disruption of avian immunoglobulin genes
09/25/2003US20030181710 Death domain-containing receptor polynucleotides, polypeptides, and antibodies
09/25/2003US20030181709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181708 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181707 Secreted transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181706 Inflammation-associated polynucleotides
09/25/2003US20030181703 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181702 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181701 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181700 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181699 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181698 PRO polypeptides; fused to heterologous polypeptide sequences
09/25/2003US20030181697 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181696 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181695 Methods of treating vascular inflammatory pathology by multiple administration of chimeric anti-TNF antibodies
09/25/2003US20030181687 Heparanase activity neutralizing anti-heparanase monoclonal antibody
09/25/2003US20030181686 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181685 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181684 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181683 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181682 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181681 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181680 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181679 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/25/2003US20030181678 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
09/25/2003US20030181677 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 ... 1494